Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591-3561-15

FDA recall notice · announced March 11, 2015 · Actavis

Class II FDA/FSIS Class II: use may cause temporary or medically reversible adverse health consequences.

The product

Reason for recall

Subpotent Drug

Notes

Distribution: Nationwide
Lot/code information: Lot #: 3109554, Exp 3/31/2015; Lot #: 3111457, Exp 3/31/2015; Lot #: 3112973, Exp 7/31/2015; Lot #: 3114262, Exp 6/30/2015; Lot #: 3114076, Exp 12/31/2015; Lot #: 3115889, Exp 12/31/2015; Lot #: 3116033, Exp 12/31/2015.
Quantity: 29,405 cartons
Status: Terminated
Products in this recall event:
- Vancomycin Hydrochloride Capsules, USP, 125 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591 (D-0396-2015)
- Vancomycin Hydrochloride Capsules, USP, 250 mg, 2 x 10 count blister pack, Rx Only, Manufactured for Watson Pharma Inc., Parsippany, NJ 07054, by Patheon Pharmaceuticals Inc., Cincinnati, OH. NDC 0591 (D-0406-2015)

Source: U.S. Food and Drug Administration public recall data. This page reports official records and is not legal, medical, or repair advice.